29 November 2018

Stan Gielen (president NWO) handed out the Dutch Data Prize (Nederlandse Data Prijs) to the BBMRI-Omics data collection. BBMRI-NL, the Biobanking and Biomolecular resources Research Infrastructure in the Netherlands, directed a program for the large scale collection of molecular (DNA, RNA, protein, metabolite) data from samples in Dutch biobanks.

The partners in BBMRI-omics, including Peter-Bram ’t Hoen (CMBI), theme Nanomedicine, made these data collections accessible to the scientific community and facilitated the discovery of new disease mechanisms.  

The jury report states: ‘BBMRI-omics is the result of a unique collaboration between a large number of researchers in Dutch research centres and a large number of Dutch biobanks. The resource provides a new dimension to the use of data in the medical sciences”.  Bas Heijmans, the researcher from LUMC’s Biomedical Data Science department coordinating the application, explains how the prize of € 5,000 will be spent: ‘BBMRI-omics was recently extensively revised and updated. We will use the money to organize trainings for young researchers so that they can get even more out of the dataset”.  

BBMRI-Omics includes data from the Genome-of-the-Netherlands and the Biobank-based Integrative -Omics Study. These studies facilitated the study of the impact of genetic variants on the epigenome, the RNA, and the ultimate clinical phenotypes. Tens of publications resulting from these studies demonstrated the opportunities for studying and prevention of disease. The collaborative projects also helped to build up expertise required for future big data projects and their underlying infrastructures.

More information on the BBMRI-Omics data resources: link.
More information on the Dutch Data Prize: link.

Related news items


Ritalin enhances your ability to do tasks by making you more motivated

26 March 2020

A new study uncovers how stimulants like Ritalin work in the brain, and it challenges some misconceptions for its recreative use. The collaboration between Radboudumc and Brown University (USA) was published in the journal Science.

read more

Dealing with COVID-19 in low- and middle-income countries

26 March 2020

RIHS researcher Joost Hopman believes that low-and middle-income countries should intensify their preparedness for a possible COVID-19 outbreak. This was the core message of an opinion article that he wrote at the request of the medical journal JAMA.

read more

Physiotherapy is important to the recovery of patients with the coronavirus

26 March 2020

Patients who have been infected with the coronavirus and admitted to the hospital for this reason should receive physiotherapy as soon as their condition allows. This is the view expressed by physiotherapists and researchers from the Radboudumc in a set of joint treatment recommendations.

read more

Healthcare utilization and regional variation of end-of-life hospital care in Dutch cancer patients

26 March 2020

In International Journal of Quality Health Care RIHS researcher Femke Atsma showed high healthcare utilization and medical variation in End of Life care in Cancer patients, which was not associated with GP care or long term care.

read more

Study into better protection for healthcare workers against coronavirus infection

19 March 2020

Radboudumc and UMC Utrecht will investigate whether health care workers are better protected against the coronavirus after a vaccination against tuberculosis (BCG vaccine). This vaccine does not directly protect against the coronavirus, but provides a boost to the immune system.

read more

Differences in the placental disposition of TNF inhibitors uncovered

19 March 2020

In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept.

read more